GBp 10.5
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 32.55 Million | 11.29 Million | 19.88 Million | 11.66 Million | 22.25 Million | -6.99 Million |
Net Income | -21.34 Million | 17.73 Million | -60.93 Million | -53.86 Million | 39.48 Million | 30.49 Million |
Depreciation & Amortization | 1.18 Million | 677 Thousand | 722 Thousand | 594 Thousand | 392 Thousand | 272 Thousand |
Deferred income taxes | 1.4 Million | - | 50.34 Million | 37.54 Million | -38.63 Million | -35.53 Million |
Stock-based compensation | 354 Thousand | 1.23 Million | 127 Thousand | 109 Thousand | 156 Thousand | 282 Thousand |
Change in working capital | 10.53 Million | 1.54 Million | 893 Thousand | -7.83 Million | 3.69 Million | -16.67 Million |
Other non-cash items | 40.42 Million | -9.9 Million | 28.72 Million | 35.11 Million | 17.16 Million | 14.17 Million |
Investing Cash Flow | 26.9 Million | -52.85 Million | -1.53 Million | -5.45 Million | -113.4 Million | -59.34 Million |
Investments in PPE | -295 Thousand | -117 Thousand | -180 Thousand | -731 Thousand | -896 Thousand | -685 Thousand |
Acquisitions | -10.54 Million | -35.14 Million | -8.49 Million | -2.33 Million | -14.05 Million | -10.1 Million |
Investment purchases | - | - | - | -1000.00 | - | -3.84 Million |
Sales/Maturities of investments | - | - | - | -20.73 Million | - | 36.39 Million |
Other Investing Activities | 37.75 Million | -17.59 Million | 7.14 Million | 18.35 Million | -98.45 Million | -81.09 Million |
Financing Cash Flow | -75.05 Million | 63.78 Million | -9.92 Million | -17.94 Million | 103.39 Million | 36.52 Million |
Debt repayment | -344.87 Million | -27.71 Million | -41 Million | -124.92 Million | -104.9 Million | -74.94 Million |
Dividends payments | -22.61 Million | -11.8 Million | -4.77 Million | -36.47 Million | -33.14 Million | -14.9 Million |
Common Stock Repurchased | -94 Thousand | - | - | - | -3.59 Million | -85 Thousand |
Common Stock Issuance | 292.97 Million | 54.48 Million | 9.81 Million | - | 126.12 Million | - |
Other Financing Activities | -433 Thousand | 48.81 Million | 26.05 Million | 143.45 Million | 118.92 Million | 126.45 Million |
Accounts receivables | 7.19 Million | 1.82 Million | 190 Thousand | -7.09 Million | -4.91 Million | -5.75 Million |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 3.33 Million | -281 Thousand | 703 Thousand | -742 Thousand | 8.61 Million | -11.11 Million |
Cash at beginning of period | 24.14 Million | 2.31 Million | -5.62 Million | 6.67 Million | -5.81 Million | 24.23 Million |
Cash at end of period | 7.33 Million | 24.14 Million | 2.31 Million | -5.62 Million | 6.67 Million | -5.81 Million |
Capital Expenditure | -295 Thousand | -117 Thousand | -180 Thousand | -731 Thousand | -896 Thousand | -685 Thousand |
Effect of forex changes on cash | -1.22 Million | -393 Thousand | -492 Thousand | -568 Thousand | 239 Thousand | -229 Thousand |
Net cash flow / Change in cash | -16.81 Million | 21.83 Million | 7.94 Million | -12.3 Million | 12.48 Million | -30.04 Million |
Free Cash Flow | 32.25 Million | 11.17 Million | 19.7 Million | 10.93 Million | 21.36 Million | -7.67 Million |
Breakdown | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 | 2022 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -9.27 Million | -9.27 Million | -21.34 Million | -14.18 Million | -14.18 Million | 2.37 Million |
Depreciation & Amortization | 383 Thousand | 383 Thousand | 1.18 Million | 316.5 Thousand | 316.5 Thousand | 141 Thousand |
Deferred income taxes | - | - | 1.4 Million | -878 Thousand | -878 Thousand | 701 Thousand |
Stock-based compensation | 50 Thousand | 50 Thousand | 354 Thousand | -29.5 Thousand | -29.5 Thousand | 206.5 Thousand |
Change in working capital | 763.5 Thousand | 763.5 Thousand | 10.53 Million | 4.5 Million | 4.5 Million | -907.5 Thousand |
Other non-cash items | 11.85 Million | 11.85 Million | 40.42 Million | 20.33 Million | 20.33 Million | 3.52 Million |
Investing Cash Flow | -2.29 Million | -2.29 Million | 26.9 Million | 2.16 Million | 2.16 Million | 11.28 Million |
Investments in PPE | - | - | -295 Thousand | - | - | - |
Acquisitions | - | - | -10.54 Million | 63.5 Thousand | 63.5 Thousand | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -2.29 Million | -2.29 Million | 37.75 Million | 2.1 Million | 2.1 Million | 11.28 Million |
Financing Cash Flow | -2.62 Million | -2.62 Million | -75.05 Million | -14.34 Million | -14.34 Million | -23.18 Million |
Debt repayment | - | - | -344.87 Million | - | - | - |
Dividends payments | - | - | -22.61 Million | -7 Million | -7 Million | -4.3 Million |
Common Stock Repurchased | - | - | -94 Thousand | -47 Thousand | -47 Thousand | - |
Common Stock Issuance | - | - | 292.97 Million | - | - | - |
Other Financing Activities | -2.62 Million | -2.62 Million | -433 Thousand | -7.28 Million | -7.28 Million | -18.88 Million |
Accounts receivables | 763.5 Thousand | 763.5 Thousand | 7.19 Million | 4.5 Million | 4.5 Million | -907.5 Thousand |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | 3.33 Million | - | - | - |
Cash at beginning of period | - | - | 24.14 Million | - | 10.64 Million | 17.39 Million |
Cash at end of period | -1.28 Million | -1.28 Million | 7.33 Million | -1.65 Million | -1.65 Million | 10.64 Million |
Capital Expenditure | - | - | -295 Thousand | - | - | - |
Effect of forex changes on cash | -150.5 Thousand | -150.5 Thousand | -1.22 Million | -419 Thousand | -419 Thousand | -192 Thousand |
Net cash flow / Change in cash | -1.28 Million | -1.28 Million | -16.81 Million | -1.65 Million | -12.3 Million | -6.75 Million |
Free Cash Flow | 3.78 Million | 3.78 Million | 32.25 Million | 10.93 Million | 10.93 Million | 5.33 Million |
TFCILTD
MMM
TSIHF
JUBLPHARMA
300220
CTRL